NUVB Q3 2025 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena

NUVBNuvation Bio Inc.

$2B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M+1704.7% YoY

Gross Profit

$10M74.5% margin

Operating Income

-$56M-430.1% margin

Net Income

-$56M-425.2% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+171.5%

Cash Flow

Operating Cash Flow

-$53M

Free Cash Flow

-$53M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$602M

Total Liabilities

$276M

Stockholders' Equity

$326M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$727,000	+1704.7%
Gross Profit	$10M	-$788,000	+1340.0%
Operating Income	-$56M	-$48M	-17.3%
Net Income	-$56M	-$41M	-35.4%